Weaver Capital Management LLC lessened its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.0% in the 3rd quarter ...

GAM Holding AG raised its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 55.3% in the third quarter, ...

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A new bombshell has been dropped in the scandal-plagued world of Alzheimer’s disease drug development. | Between the two ...

The company is suing some online vendors and medical spas for selling copycats of a weight loss and diabetes drug.

In this piece, we will look at where Eli Lilly and Company (NYSE:LLY) sits on the fund managers’ radar. The surge in interest surrounding artificial intelligence has meant that […] Lilly (LLY ...

Lots of money is pouring into two critical races for Washington's legislature this year — and some big name companies are ...

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading pharmaceutical company that sells Trulicity, Verzenio, and Taltz drugs. The company discovers, develops, and markets human ...

Eli Lilly (LLY) is suing medical spas and online vendors who claim their products contain the main ingredients of GLP-1 weight-loss drug Zepbound, according to Reuters. Lastly, Bloomberg reports that ...